PRGO May 2024 25.000 call
| Previous close | 8.00 |
| Open | 8.00 |
| Bid | 7.00 |
| Ask | 9.70 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 8.00 - 8.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 142 |
PR NewswirePerrigo Announces Quarterly Dividend
Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.276 per share, payable on June 18, 2024, to shareholders of record on May 31, 2024.
ZacksPerrigo (PRGO) to Report Q1 Earnings: Here's What to Expect
Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the top line in the soon-to-be-reported quarter.
- PR Newswire
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that pharmaceutical company Esteve Healthcare, S.L. ("ESTEVE") has signed a binding offer to acquire Perrigo's HRA Pharma Rare Diseases business for a total consideration of up to €275 million, consisting of an upfront cash payment of €190 million and up to €85 million in potential earnout payments based on the Rare Diseases business achieving certain sales milestones.
